Výsledky vyhledávání - Ashish M. Ingle
- Zobrazuji výsledky 1 - 19 z 19
-
1
-
2
Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's O... Autor Stacey L. Berg, Mitchell S. Cairo, Heidi V. Russell, Janet Ayello, Ashish M. Ingle, Henry Lau, Nianhang Chen, Peter C. Adamson, Susan M. Blaney
Vydáno 2010Artigo -
3
Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium Autor Richard Aplenc, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish M. Ingle, Shruti Agrawal, Junfeng Sun, James R. Wright, Peter C. Adamson
Vydáno 2011Artigo -
4
Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report Autor Jack M. Su, Xiao‐Nan Li, Patrick Thompson, Ching-Nan Ou, Ashish M. Ingle, Heidi V. Russell, Ching C. Lau, Peter C. Adamson, Susan M. Blaney
Vydáno 2010Artigo -
5
Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncol... Autor Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss, Elizabeth Fox, Anthony Little, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney
Vydáno 2013Artigo -
6
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I c... Autor Lars M. Wagner, John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, Peter C. Adamson
Vydáno 2010Artigo -
7
Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study Autor Regina I. Jakacki, Marta Hamilton, Richard J. Gilbertson, Susan M. Blaney, Jean M. Tersak, Mark Krailo, Ashish M. Ingle, Stephan D. Voss, Janet Dancey, Peter C. Adamson
Vydáno 2008Artigo -
8
A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112) Autor Patrick A. Thompson, Rachid Drissi, Jodi A. Muscal, Eshini Panditharatna, Maryam Fouladi, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Tong Lin, Brenda J. Weigel, Susan M. Blaney
Vydáno 2013Artigo -
9
A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report Autor Brigitte C. Widemann, AeRang Kim, Elizabeth Fox, Sylvain Baruchel, Peter C. Adamson, Ashish M. Ingle, Julia Glade Bender, Michael Burke, Brenda J. Weigel, Diana Stempak, Frank M. Balis, Susan M. Blaney
Vydáno 2012Artigo -
10
Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study Autor Steven G. DuBois, Suzanne Shusterman, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Bing Wu, Sylvain Baruchel, Julia Glade Bender, Percy Ivy, Holcombe E. Grier, Peter C. Adamson, Susan M. Blaney
Vydáno 2011Artigo -
11
Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortiu... Autor Julia Glade Bender, Alice Lee, Joel M. Reid, Sylvain Baruchel, Timothy P. L. Roberts, Stephan D. Voss, Bing Wu, Charlotte H. Ahern, Ashish M. Ingle, Pamela Jo Harris, Brenda J. Weigel, Susan M. Blaney
Vydáno 2013Artigo -
12
A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916) Autor Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton, Ashish M. Ingle, Charlotte H. Ahern, Renee M. McGovern, Joel M. Reid, Matthew M. Ames, Igor Espinoza‐Delgado, Brenda J. Weigel, Susan M. Blaney
Vydáno 2012Artigo -
13
Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report Autor Maryam Fouladi, Julie R. Park, Clinton F. Stewart, Richard J. Gilbertson, Paula Schaiquevich, Junfeng Sun, Joel M. Reid, Matthew M. Ames, Roseanne Speights, Ashish M. Ingle, James A. Zwiebel, Susan M. Blaney, Peter C. Adamson
Vydáno 2010Artigo -
14
Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report Autor Maryam Fouladi, Wayne L. Furman, Thomas K. Chin, Burgess B. Freeman, Lorina Dudkin, Clinton F. Stewart, Mark Krailo, Roseanne Speights, Ashish M. Ingle, Peter J. Houghton, James R. Wright, Peter C. Adamson, Susan M. Blaney
Vydáno 2006Artigo -
15
A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study Autor Trent R. Hummel, Lars M. Wagner, Charlotte H. Ahern, Maryam Fouladi, Joel M. Reid, Renee M. McGovern, Matthew M. Ames, Richard J. Gilbertson, Terzah M. Horton, Ashish M. Ingle, Brenda J. Weigel, Susan M. Blaney
Vydáno 2013Artigo -
16
A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study Autor Brenda J. Weigel, Susan M. Blaney, Joel M. Reid, Stephanie L. Safgren, Rochelle Bagatell, John Kersey, Joseph P. Neglia, S. Percy Ivy, Ashish M. Ingle, Luke Whitesell, Richard J. Gilbertson, Mark Krailo, Matthew M. Ames, Peter C. Adamson
Vydáno 2007Artigo -
17
Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group Autor Suman Malempati, Brenda J. Weigel, Ashish M. Ingle, Charlotte H. Ahern, Julie M. Carroll, Charles T. Roberts, Joel M. Reid, Stephen C. Schmechel, Stephan D. Voss, Steven Y. Cho, Helen X. Chen, Mark Krailo, Peter C. Adamson, Susan M. Blaney
Vydáno 2011Artigo -
18
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study Autor Yaël P. Mossé, Megan S. Lim, Stephan D. Voss, Keith D. Wilner, Katherine Ruffner, Julie Laliberté, Delphine C.M. Rolland, Frank M. Balis, John M. Maris, Brenda J. Weigel, Ashish M. Ingle, Charlotte H. Ahern, Peter C. Adamson, Susan M. Blaney
Vydáno 2013Artigo -
19
Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study Autor Julia Glade Bender, Peter C. Adamson, Joel M. Reid, Lu Xu, Sylvain Baruchel, Yuval Shaked, Robert S. Kerbel, Erin Cooney-Qualter, Diana Stempak, Helen X. Chen, Marvin D. Nelson, Mark Krailo, Ashish M. Ingle, Susan M. Blaney, Jessica J. Kandel, Darrell J. Yamashiro
Vydáno 2008Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Oncology
Gastroenterology
Astrobiology
Pharmacokinetics
Refractory (planetary science)
Pharmacology
Physics
Toxicity
Cancer
Biochemistry
Chemistry
Chemotherapy
Neutropenia
Pharmacodynamics
Adverse effect
Gene
Phases of clinical research
Temozolomide
Biology
Histone
Histone deacetylase
Pathology
Rash
Sarcoma
Tolerability
Vorinostat
Colorectal cancer
In vitro